March 16, 2017 — MedyMatch Technology announced a collaboration with IBM Watson Health to bring MedyMatch’s artificial ...
During the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC), March 17-19 in Washington, D.C., Siemens Healthineers will showcase technologies that integrate images and information at every step of the treatment process, with a theme of “Making Complex Simple.”
Parascript will exhibit at the National Consortium of Breast Centers (NCoBC) 27th Conference, March 11-17, 2017, in Las Vegas, where the company will provide a demo of its AccuDetect Computer-Aided Detection (CAD) for Mammography.
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
Researchers at the University of California Irvine now have access to Toshiba Medical’s most advanced magnetic resonance (MR) technology for their cutting-edge neurology work investigating cerebral microbleeds (CMB) in high school football players as a potential precursor to chronic traumatic encephalopathy (CTE). As part of its ongoing, first-of-its-kind study to identify early signs of brain trauma in young athletes, UCI doctors will now leverage Toshiba Medical’s Vantage Galan 3T MR system as a key diagnostic tool.
March 15, 2017 — Scientists at University College London (UCL) have developed a way to use magnetic resonance imaging ...

SPONSORED CONTENT — EnsightTM 2.0 is the newest version of Enlitic’s data standardization software framework. Ensight is ...
CAD Inc. announced that more than 3,000 early-stage breast cancer patients have been treated with intraoperative radiation therapy (IORT) using the Xoft Axxent Electronic Brachytherapy (eBx) System. The Xoft System and its suite of products were showcased in the Xoft booth during Physicians’ Education Resource (PER)’s 34th Annual Miami Breast Cancer Conference at the Fontainebleau Miami Beach Hotel in Miami Beach, Fla., March 9-12, 2017.
While most women understand the importance of health screenings, an estimated 72 million have missed or postponed a ...
A new study in the journal Chest determined that a structured prescreening counseling and shared decision-making visit with healthcare professionals leads to a better understanding of the benefits and risks of low-dose computed tomography (CT) lung cancer screening. The study found this also improved understanding of the eligibility criteria.
The U.S. Food and Drug Administration (FDA) has cleared the Artis pheno robotic C-arm angiography system from Siemens Healthineers created for use in minimally invasive interventional procedures.
International medical imaging IT and cybersecurity company Sectra has signed a ten-year contract with Isala Hospital, in the Netherlands. The contract comprises Sectra’s information technology (IT) solution for reviewing diagnostic images. The solution enables physicians at Isala Hospital to access and review medical images from any of its two hospitals, regardless of where current and prior images were taken. The joint solution also enables the two sites to efficiently share resources.
Fujifilm’s APERTO Lucent is a 0.4T mid-field, open MRI system addressing today’s capability and image quality needs ...
The Society of Interventional Radiology (SIR) presented its highest honor, the SIR Gold Medal, to three individuals during its 2017 Annual Scientific Meeting, March 4-9 in Washington, D.C. These awards acknowledge distinguished and extraordinary service to SIR or to the discipline of interventional radiology.
Noninvasive computed tomography (CT) angiography and stress tests can help predict which patients are likely to suffer a heart attack or other adverse cardiovascular event, according to a new study appearing online in the journal Radiology.
March 14, 2017 — Over half of older women with early stage breast cancer received more radiation therapy than what might ...
SPONSORED CONTENT — Fujifilm’s latest CT technology brings exceptional image quality to a compact and user- and patient ...
Hologic Inc. highlighted its portfolio of innovative breast cancer screening and interventional products, including new solutions for biopsy workflow, at the European Congress of Radiology (ECR) in Vienna, Austria, March 1-5. The company also hosted a symposium and several educational workshops throughout the show, giving attendees opportunities to experience screening and interventional products that offer unique patient and user benefits and address workflow challenges.
FDG positron emission tomography/computed tomography (PET/CT) is a valuable imaging tool for treatment assessment of patients with lung cancer, though systematic evidence for its comparative effectiveness with conventional imaging, such as chest CT, is still evolving, according to a new study.
Stratasys Ltd. announced last week enrollment is now open for 3DHEART, an investigator-initiated trial. 3DHEART, which stands for 3D Hearts Enabling A Randomized Trial, is a randomized, single-blind clinical trial to study the use of patient-specific 3-D-printed models in pre-operative planning for pediatric heart surgery. Stratasys is providing in-kind support with printing of the models to be used in the trial.
A new study shows women at high risk for breast cancer were more likely to return for additional screening with magnetic resonance imaging (MRI) if they received a letter informing them of their options for additional imaging. The letter (in addition to a letter sent to their primary care physician) — which is included in the paper published in Health Communications — may help breast imaging centers navigate the complex legal, ethical and institutional landscapes in a way that increases the likelihood that women will follow through with American Cancer Society breast cancer screening recommendations for adjunct breast screening in women at elevated risk.
TeraMedica, a division of Fujifilm Medical Systems USA, demonstrates Connext Mobile V2 and other new product features.
A new research study by the Harvey L. Neiman Health Policy Institute assesses relationships between county-level variation in Medicare beneficiary imaging resource consumption and measures of population economic status. The study, published online in the Journal of the American College of Radiology (JACR), found that in the Medicare population, imaging utilization and costs vary greatly at the county level, and far more than at the state level.
The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency recently released new recommendations on procedures employing gadolinium-based contrast agents, in which the committee recommended suspension of marketing authorization for four agents.
Radiology provides some of the easiest targets for cyber criminals. Continued use of outdated imaging systems and a growing interest in enterprise imaging are among the reasons.